Do you want to read an article? Please log in or register.
What matters most to patients when choosing treatment for mild-moderate asthma? Results from a discrete choice experiment
Asthma
RECOMMENDED
Related content
Asthma
Benralizumab for patients with mild to moderate, persistent asthma (BISE): a randomised, double-blind, placebo-controlled, phase 3 trial
Lancet Respir Med.
Ferguson GT, FitzGerald JM, Bleecker ER, Laviolette M, Bernstein D, LaForce C, Mansfield L, Barker P, Wu Y, Jison M, Goldman M; BISE Study Investigators
doi: 10.1016/
RECOMMENDED
AsthmaCOPD
Maintenance inhaler therapy preferences of patients with asthma or chronic obstructive pulmonary disease: a discrete choice experiment
★ 2
Recommended by
Dr Martin Frey, Faculty Member
Thorax.
Tervonen T, Hawken N, Hanania NA, Martinez FJ, Heidenreich S, Gilbert I
doi: 10.1136/thoraxjnl-2019-213974.
RECOMMENDED
Asthma
Impact of patient satisfaction with his or her inhaler on adherence and asthma control
Allergy Asthma Proc.
Plaza V, Giner J, Calle M, Rytilä P, Campo C, Ribó P, Valero A
doi: 10.2500/aap.2018.39.4183.
RECOMMENDED
Asthma
Patient preferences for symptom-driven or regular preventer treatment in mild to moderate asthma - findings from the PRACTICAL study, a randomised clinical trial
★ 2
Recommended by
Dr Martin Frey, Faculty Member
★ 1
Recommended by
Dr Marcus Hesse, Faculty Member
Eur Respir J.
Baggott C, Reddel HK, Hardy J, Sparks J, Holliday M, Corin A, Montgomery B, Reid J, Sheahan D, Hancox RJ, Weatherall M, Beasley R, Fingleton J, PRACTICAL study team.
doi: 10.1183/13993003.02073-2019.
Asthma
Biologic treatment eligibility for real-world patients with severe asthma: The IDEAL study
J Asthma.
Albers FC, Müllerová H, Gunsoy NB, Shin JY, Nelsen LM, Bradford ES, Cockle SM, Suruki RY
doi: 10.1080/02770903.
RECOMMENDED
Asthma
Anti-IL-5 treatments in patients with severe asthma by blood eosinophil thresholds: Indirect treatment comparison
J Allergy Clin Immunol.
Busse W, Chupp G, Nagase H, Albers FC, Doyle S, Shen Q, Bratton DJ, Gunsoy NB
doi: 10.1016/j.jaci.2018.08.031.
RECOMMENDED
Asthma
Medical Costs and Productivity Loss Due to Mild, Moderate, and Severe Asthma in the United States
★ 2
Recommended by
Dr Martin Frey, Faculty Member
J Asthma Allergy.
Song HJ, Blake KV, Wilson DL, Winterstein AG, Park H
doi: 10.2147/JAA.S272681.Visit the original publication at ncbi.nlm.nih.gov
Asthma
Omalizumab Improves Quality of Life and Asthma Control in Chinese Patients With Moderate to Severe Asthma: A Randomized Phase III Study
Allergy Asthma Immunol Res.
Li J, Kang J, Wang C, Yang J, Wang L, Kottakis I, Humphries M, Zhong N; China Omalizumab Study Group
doi: 10.4168/aair.2016.8.4.319.
RECOMMENDED
Asthma
Health-Related Quality of Life and Health Utilities of Mild, Moderate, and Severe Asthma: Evidence from the Medical Expenditure Panel Survey
★ 1
Recommended by
Dr Martin Frey, Faculty Member
J Asthma Allergy
Song HJ, Blake KV, Wilson DL, Winterstein AG, Park H
doi: 10.2147/JAA.S316278